hakkında

The onset of the millennium was accompanied by a significant surge in both testosterone testing and initiation of testosterone replacement, especially in men without clear indications (1). By dissecting the hypothalamic-pituitary-gonadal axis, we demonstrated that the cause of low testosterone was a decrease in testicular responsiveness to luteinizing hormone (LH). Testosterone's intricate role extends to potential benefits in glycemic control, fat mass reduction, and muscle strength increase in men with diabetes. Sex-specific differences in glucose metabolism highlight males' lower insulin sensitivity and less effective glucose utilization compared to females due to androgenic effects.
Free testosterone levels below 225 pmol/L (65 pg/mL) indicate a pathology and necessitate replacement therapy . Based on our results, we hypothesize that TRT can improve glycemic control and hormone levels, as well as lower total cholesterol, triglyceride, and LDL cholesterol levels while raising HDL cholesterol in hypogonadal type 2 diabetes patients. There was a small increase in non-fatal cardiac events in men taking testosterone therapy, which was more marked in those with increased risk. A study analysing prescribing data in men treated with testosterone therapy , without records of blood results or symptoms, defined non-fatal coronary events as the major endpoint, assessed in the 12 months before and 3 months after therapy.
The diagnosis of low testosterone should be made only after two total testosterone measurements are taken on separate occasions with both conducted in an early morning fashion. When sufficient evidence existed, the body of evidence for a particular treatment was assigned a strength rating of A (high), B (moderate) or C (low) for support of Strong, Moderate, or Conditional Recommendations. The AUA and the Testosterone Panel were committed to creating a Guideline that ensures that men in need of testosterone therapy are treated effectively and safely.
Smoking cessation, reduction and exercise have been shown to improve insulin sensitivity and should always be offered in conjunction with other therapies . Low testosterone has been demonstrated to be closely linked with components of the metabolic syndrome in T2DM . However, the conclusions from a review on testosterone and mortality were that low testosterone could be a ‘marker’ of illness 27,28. 9.1% in the normal testosterone group, independent of comorbidities and therapies, and 9.4% in those with TD in the treated group .
Postulated mechanisms are postulated as protection against endothelial reperfusion injury, improved endothelial function and reduced systemic and pulmonary blood pressure . Earlier safety data from licensing studies showed similar trends but mortality reduction was not a primary outcome and studies were powered to show safety and not benefit. Two longitudinal studies have assessed long term mortality, exclusively in men with T2DM.
In summary, the connection between low testosterone and diabetes is significant. Proper treatment and lifestyle changes are key to reducing these risks and maintaining a healthy life. For men with both low testosterone and diabetes, managing both conditions is critical. Testosterone replacement therapy (TRT) has been shown to help some men with low T and diabetes. Many people are unaware of the important role testosterone plays in the body.